BioCentury
ARTICLE | Company News

Celgene sales and marketing update

July 20, 2015 7:00 AM UTC

The German Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier assessment that added benefit cannot be derived for Otezla apremilast to treat moderate to severe plaque psori...